Literature DB >> 1105500

L-dopa and carbidopa (sinemet) in the management of parkinsonism.

E Critchley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1105500      PMCID： PMC2496211          DOI： 10.1136/pgmj.51.599.619

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  Sustained levodopa therapy in parkinsonism.

Authors:  K R Hunter; K M Shaw; D R Laurence; G M Stern
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

2.  A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone.

Authors:  C D Marsden; J D Parkes; J E Rees
Journal:  Lancet       Date:  1973-12-29       Impact factor: 79.321

3.  Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease.

Authors:  P M Horrocks; D J Vicary; J E Rees; J D Parkes; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-12       Impact factor: 10.154

4.  Levodopa and amantadine in the treatment of Parkinsonism.

Authors:  E Critchley
Journal:  Practitioner       Date:  1972-04

5.  Levodopa in Parkinsonism: the effects of withdrawal of anticholinergic drugs.

Authors:  R C Hughes; J G Polgar; D Weightman; J N Walton
Journal:  Br Med J       Date:  1971-05-29
  5 in total
  1 in total

1.  Management of L-dopa overdose in the competitive inhibition state.

Authors:  Marty Hinz; Alvin Stein; Ted Cole
Journal:  Drug Healthc Patient Saf       Date:  2014-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.